New antibody approved for treatment of rheumatoid arthritis
- PMID: 12688444
- DOI: 10.1331/108658003321480812
New antibody approved for treatment of rheumatoid arthritis
Abstract
Adalimumab joins free existing biologic agents for the treatment of RA. Its place among these therapeutic options is unclear until head-to-head studies are performed with adalimumab and other biologic DMARDs. Adalimumab is currently in clinical trials for additional therapeutic uses, namely Crohn's disease and coronary artery disease.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
